Predictive Role of Temporal Changes in Intratumoral Metabolic Heterogeneity During Palliative Chemotherapy in Patients with Advanced Pancreatic Cancer: A Prospective Cohort Study

Conclusion: Reduction in metabolic ITH during palliative chemotherapy in advanced pancreatic cancer patients is associated with treatment response and might be predictive of PFS and OS.

Source: Journal of Nuclear Medicine - January 1, 2020 Category: Nuclear Medicine Authors: Yoo, S. H., Kang, S. Y., Cheon, G. J., Oh, D.-Y., Bang, Y.-J. Tags: Clinical Source Type: research